Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Economy & Forex  >  All News

News : Economy & Forex
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
All NewsEconomyCurrencies / ForexCryptocurrenciesEconomic EventsPress releases

News Highlights: Top Company News of the Day

share with twitter share with LinkedIn share with facebook
share via e-mail
10/24/2019 | 05:15pm EST
CVS to Halt Sales of Some J&J Talcum Powder After Recall 

CVS Health said it is removing 22 oz. bottles of Johnson's Baby Powder from pharmacy shelves and its online store in response to Johnson & Johnson's recall of certain bottles last week, after regulators found asbestos in one.

Citigroup Names Jane Fraser as President 

Citigroup Chief Executive Michael Corbat named Jane Fraser as his No. 2, signaling that she is the most likely candidate to replace him.

Visa Reports Better-Than-Expected Revenue 

Higher spending on Visa's credit and debit cards drove profit and revenue higher in the latest quarter.

Amazon's Third-Quarter Profit Slides 26% 

Amazon's profit machine sputtered again after more than two years of surging growth, weighed down by the tech giant's heavy investment into reducing shipping times for retail customers.

Intel Raises Outlook, Sending Shares Higher 

Intel's third-quarter earnings rose and the chip maker again raised its full-year outlook, helping ease investor concerns over softening demand.

Vale's Third-Quarter Net Income Rises on Higher Production 

Vale's profit jumped in the third quarter as production increased, prices rose and the financial impact of the deadly dam collapse at Brumadinho waned.

Barneys Moves Forward on Sale to Authentic Brands Group 

Barneys New York is moving forward with the sale of its brand and assets to a licensing company, but the bankrupt retailer hasn't completely shut the door on a rival bidder that would keep its stores open.

Amgen to Sell Cholesterol Drug for 60% Less Than Original Price 

Amgen said it will sell the cholesterol drug Repatha only at a list price 60% lower than its original price in a bid to make the medicine more affordable for patients and kick-start sales.

Tesla Turns a Corner. It May Not Be the Last One. 

Tesla this week posted just its fifth quarterly profit since going public in 2010, after accumulating a loss of more than $6 billion so far.

Gucci Sales Growth Slows, Hurt by Hong Kong Turmoil 

Sales growth at Gucci slowed to its lowest level in more than three years, as protests in Hong Kong and the aftermath of the brand's blackface scandal took their toll on the Italian fashion house.

Stocks mentioned in the article
ChangeLast1st jan.
AMGEN -0.41% 232.82 Delayed Quote.19.60%
CITIGROUP INC. -0.63% 75.33 Delayed Quote.45.62%
CVS HEALTH CORPORATION -0.49% 74.99 Delayed Quote.14.45%
INTEL CORPORATION -0.49% 56.53 Delayed Quote.20.46%
TESLA INC. 1.08% 339.53 Delayed Quote.2.02%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Economy & Forex"
01:13aAsian shares edge down as tariff deadline hems bets
12:23aIndonesia eyes biodiesel with 40% bio-content during 2021-2022
12:16aNEWS HIGHLIGHTS : Top Financial Services News of the Day
12:14aMajor currencies mark time as investors brace for key risk events
12:14aChoppy markets leave U.S. bank bonus decisions in limbo
12:10aMajor currencies mark time as investors brace for key risk events
12/09Oil prices recoil as specter of trade war, weaker demand haunts market
12/09Oil prices recoil as spectre of trade war, weaker demand haunts market
12/09China's consumer inflation at eight-year high, but PPI stuck in the red
12/09China's consumer inflation at 8-year high, but PPI stuck in the red
Latest news "Economy & Forex"